Peter M. George

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

Peter M. George, Paolo Spagnolo, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2020 · 346 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot et al. · The Lancet Rheumatology · 2020 · 300 citations

Medicine, Clinical Sciences, Internal Medicine +16

Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)

Zoltán Endre, Robert Walker, John W. Pickering et al. · Kidney International · 2010 · 280 citations · Full text

Medicine, Nephrology, Pharmacotherapy +8

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function

Zoltán Endre, John W. Pickering, Robert Walker et al. · Kidney International · 2011 · 280 citations · Full text

Medicine, Nephrology, Critical Care Medicine +15

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 239 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16